title: Altered expression of epimorphin in ulcerative colitis.
abstract: OBJECTIVE
  Epimorphin is suggested to play a key role in the morphogenesis of epithelial cells. We focused on epimorphin and attempted to clarify the relationship between expression of this molecule and inflammatory bowel disease (IBD).
  
  
  METHODS
  Colonic specimens were taken from 23 patients with ulcerative colitis (UC), 15 with Crohn's disease (CD), six with non-IBD colitis, and 10 normal controls. Distribution and expression of epimorphin protein were examined by immunohistochemistry and western blot analysis, and expression of epimorphin messenger (m)RNA by reverse transcription-polymerase chain reaction. Distribution of basic fibroblast growth factor (bFGF) was also examined by immunohistochemistry.
  
  
  RESULTS
  In the normal colonic mucosa, epimorphin was observed around the epithelial cells, in some fibroblasts, vascular endothelial cells, and macrophages. In UC patients, epimorphin around epithelial cells disappeared or decreased, and the number of epimorphin-containing cells (mean + standard error/mm2) was significantly increased in active UC patients (1550.8 +/- 144.2) compared with patients in remission (692.8 +/- 45.8), CD patients (790.0 +/- 31.2), non-IBD colitis patients (710.8 +/- 29.2), and controls (664.8 +/- 39.6) (P < 0.01). The number of bFGF-containing cells was significantly increased in active UC and CD patients compared with UC patients in remission, CD and non-IBD colitis patients, and controls (P < 0.05 or P < 0.01). Total expression of epimorphin protein and mRNA was increased in the active stage of UC. Expression of the 34 kDa epimorphin isoform decreased or disappeared in 20 out of 23 cases of UC.
  
  
  CONCLUSIONS
  Our results suggest that altered expression of epimorphin contributes to impaired healing and chronic inflammation in the colonic mucosa of UC patients.
authors.affiliation: First Department of Internal Medicine, Akita University School of Medicine, Akita, Biomedical Research and Development Department, Sumitomo Electric Industries, and Department of Surgery, Yokohama Municipal Hospital, Yokohama, Japan.
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Shirasaka
authors.forename: Masahiro
authors.initials: M
authors.lastname: Iizuka
authors.forename: Michihiro
authors.initials: M
authors.lastname: Yukawa
authors.forename: Yohei
authors.initials: Y
authors.lastname: Hirai
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Horie
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Itou
authors.forename: Shiho
authors.initials: S
authors.lastname: Kon-No
authors.forename: Tsuneo
authors.initials: T
authors.lastname: Fukushima
authors.forename: Sumio
authors.initials: S
authors.lastname: Watanabe
mesh_terms: D015153:Blotting, Western; D003093:Colitis, Ulcerative / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007413:Intestinal Mucosa / Q000378:metabolism; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D050827:Syntaxin 1
chemical_list: D008562:Membrane Glycoproteins; D012333:RNA, Messenger; C074558:STX2 protein, human; D050827:Syntaxin 1